Evotec SE (EVO) Net Cash Flow Growth (3y) (2022 - 2026)
Powered by 
Analysis
Evotec SE (EVO) Net Cash Flow Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 27.97% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | -164.05% |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 858.59% |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 168.48% |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 63.95% |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 42.13% |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | -13.88% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 66.80% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -85.81% |
| Dec 31, 2025 | 58.59% |
| Sep 30, 2025 | -35.89% |
| Jun 30, 2025 | -34.30% |
| Mar 31, 2025 | 23.32% |
| Dec 31, 2024 | -1.83% |
| Sep 30, 2024 | -48.77% |
| Jun 30, 2024 | -49.76% |
| Mar 31, 2024 | -84.47% |
| Dec 31, 2022 | -62.46% |